DJIA 16,620.69 5.88 0.04%
NASDAQ 4,427.33 7.85 0.18%
S&P 500 1,943.58 2.30 0.12%
market minute promo


company name or ticker

Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Bl

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

3 Drugs Stocks Dragging The Industry Down

Rising Short Interest in Biotech Stocks

5 Rocket Stocks to Buy for S&P 2,000

UPDATE: 8-K from Alexion Pharma Shows FDA Issued Form 483 at Aug. Inspection of Site, Does Not Expec

UPDATE: 8-K from Alexion Pharma Shows FDA Issued Form 483 at Aug. Inspection of Site, Does Not Expect Material Financial Effect Related to FDA Concern

Alexion Initiates Multinational Registration Trial of Eculizumab for Prevention of DGF after Kidney

Alexion Initiates Multinational Registration Trial of Eculizumab for Prevention of DGF after Kidney Transplantation

Jim Cramer's 'Mad Money' Recap: 12 Stocks Even Better Than Google

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Anal

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog

Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog

See More Articles...